Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.
Pachón-Ibáñez ME, Docobo-Pérez F, López-Rojas R, Domínguez-Herrera J, Jiménez-Mejias ME, García-Curiel A, Pichardo C, Jiménez L, Pachón J. Pachón-Ibáñez ME, et al. Antimicrob Agents Chemother. 2010 Mar;54(3):1165-72. doi: 10.1128/AAC.00367-09. Epub 2010 Jan 4. Antimicrob Agents Chemother. 2010. PMID: 20047914 Free PMC article.
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C, del Carmen Conejo M, Bernabéu-Wittel M, Pascual A, Jiménez-Mejías ME, de Cueto M, Pachón-Ibáñez ME, García I, Pachón J, Martínez-Martínez L. Pichardo C, et al. Clin Microbiol Infect. 2005 Jan;11(1):31-8. doi: 10.1111/j.1469-0691.2004.01018.x. Clin Microbiol Infect. 2005. PMID: 15649301 Free article.
Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
Bernabeu-Wittel M, Pichardo C, García-Curiel A, Pachón-Ibáñez ME, Ibáñez-Martínez J, Jiménez-Mejías ME, Pachón J. Bernabeu-Wittel M, et al. Clin Microbiol Infect. 2005 Apr;11(4):319-25. doi: 10.1111/j.1469-0691.2005.01095.x. Clin Microbiol Infect. 2005. PMID: 15760430 Free article.
Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
Pichardo C, Rodríguez-Martínez JM, Pachón-Ibañez ME, Conejo C, Ibáñez-Martínez J, Martínez-Martínez L, Pachón J, Pascual A. Pichardo C, et al. Antimicrob Agents Chemother. 2005 Aug;49(8):3311-6. doi: 10.1128/AAC.49.8.3311-3316.2005. Antimicrob Agents Chemother. 2005. PMID: 16048941 Free PMC article.
Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
Saugar JM, Rodríguez-Hernández MJ, de la Torre BG, Pachón-Ibañez ME, Fernández-Reyes M, Andreu D, Pachón J, Rivas L. Saugar JM, et al. Antimicrob Agents Chemother. 2006 Apr;50(4):1251-6. doi: 10.1128/AAC.50.4.1251-1256.2006. Antimicrob Agents Chemother. 2006. PMID: 16569836 Free PMC article.
Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ, Saugar J, Docobo-Pérez F, de la Torre BG, Pachón-Ibáñez ME, García-Curiel A, Fernández-Cuenca F, Andreu D, Rivas L, Pachón J. Rodríguez-Hernández MJ, et al. J Antimicrob Chemother. 2006 Jul;58(1):95-100. doi: 10.1093/jac/dkl145. Epub 2006 Apr 24. J Antimicrob Chemother. 2006. PMID: 16636085
65 results